KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Operating Expenses (2016 - 2025)

Amgen (AMGN) has 17 years of Operating Expenses data on record, last reported at $7.1 billion in Q4 2025.

  • For Q4 2025, Operating Expenses rose 5.48% year-over-year to $7.1 billion; the TTM value through Dec 2025 reached $27.7 billion, up 5.75%, while the annual FY2025 figure was $27.7 billion, 5.75% up from the prior year.
  • Operating Expenses reached $7.1 billion in Q4 2025 per AMGN's latest filing, up from $7.0 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $7.1 billion in Q4 2025 and bottomed at $3.7 billion in Q1 2022.
  • Average Operating Expenses over 5 years is $5.5 billion, with a median of $5.3 billion recorded in 2021.
  • Peak YoY movement for Operating Expenses: dropped 22.46% in 2022, then soared 54.3% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $4.5 billion in 2021, then rose by 1.48% to $4.6 billion in 2022, then skyrocketed by 50.25% to $6.9 billion in 2023, then fell by 2.17% to $6.8 billion in 2024, then grew by 5.48% to $7.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $7.1 billion in Q4 2025, $7.0 billion in Q3 2025, and $6.5 billion in Q2 2025.